ADVERTISEMENT

Levonorgestrel intrauterine system superior for controlling menorrhagia

Author and Disclosure Information
Approval of levonorgestrel-IUS should be broadened in U.S.

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Given that menorrhagia often persists for years, longer follow-up of these study subjects is planned. Additional intention-to-treat analyses will be done at 5 and 10 years, Dr. Gupta and his associates said.

This study was supported by the National Institute of Health Research Health Technology Assessment Programme. Dr. Gupta reported ties to Hodder Arnold Publishing, Ethicon Gynecare, and Femcare-Nikomed.